scispace - formally typeset
R

Ramesh Nachimuthu

Researcher at VIT University

Publications -  40
Citations -  712

Ramesh Nachimuthu is an academic researcher from VIT University. The author has contributed to research in topics: Phage therapy & Biology. The author has an hindex of 10, co-authored 27 publications receiving 343 citations.

Papers
More filters
Journal ArticleDOI

Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species.

TL;DR: All the characterized phages were found to have a broad host range activity and the prepared phage cocktails were effective against mixed bacterial population that are resistant to meropenem and colistin, two last resort antibiotics.
Journal ArticleDOI

Secondary Bacterial Infections in Patients With Viral Pneumonia

TL;DR: Clinical data of secondary bacterial infections developed after the onset of pulmonary viral infections and their treatment in SARS-CoV-2 positive patients are reviewed and treatments used or prophylactic measures employed are outlined.
Journal ArticleDOI

Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-A protocol for systematic review and meta-analysis.

TL;DR: This meta-analysis protocol examines the comparative utility of neutrophil-lymphocyte-ratio, platelet-ly mphocyte- ratio, and monocyte-lyymphocyte-Ratio as a simple, inexpensive, and effective method for cancer prognosis, in multiple cancers.
Journal ArticleDOI

The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model

TL;DR: The data shows that although in vitro studies showed high infectivity of phages, for in vivo models multiple phage doses were required for effective treatment.
Journal ArticleDOI

Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?

TL;DR: In this paper, the potential of phage therapy and phage-derived therapeutic proteins and strategies in treating secondary bacterial infections, including their application in combination with chemical antibiotics, were explored.